Drug Topics

JUNE 6, 2025

Mayo Clinic. McDowell C, Farooq U, Haseeb M. Inflammatory Bowel Disease. Updated 2023 Aug 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: [link] 4. Inflammatory bowel disease (IBD). December 18, 2024. Accessed June 6, 2025. Crohn’s and Colitis Foundation. IBD Pharmacists.

FDA 281

FDA Immunization Mayo Clinic Dosage 281

Drug Topics

JUNE 24, 2025

Mayo Clinic. REFERENCES 1. FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis. News release. June 24, 2025. Accessed June 24, 2025. Lupus nephritis. January 31, 2025. Accessed June 24, 2025. FDA approves Benlysta (belimumab) Autoinjector for children with systemic lupus erythematosus.

FDA 509

FDA Vaccines Immunization Mayo Clinic 509

PharmD Live

JUNE 16, 2025

Journal of Managed Care & Specialty Pharmacy, 28 (3), 379–386. Mayo Clinic Proceedings, 86 (4), 304–314. The role of integrated medical and prescription drug plans in addressing racial and ethnic disparities in medication adherence. link] Brown, M. T.,  T., & Bussell, J. K. Medication adherence: WHO cares?

Hospitals 59

Hospitals Mayo Clinic Specialty Pharmacies Communication 59

Pharmacy Times

JUNE 16, 2025

Mayo Clinic. Pharmacy Times. RAD 2025: Long-term data on Nemluvio® (nemolizumab) demonstrate its favorable safety profile and sustained and increased improvements in itch and skin lesions in patients with atopic dermatitis up to two years. News release. June 6, 2025. Accessed June 16, 2025. Atopic Dermatitis. News release.

Compounding Pharmacies 65

Compounding Pharmacies FDA Immunization Mayo Clinic 65

Pharmacy Times

JUNE 20, 2025

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Compounding Pharmacies 65

Compounding Pharmacies Immunization Mayo Clinic Hospitals 65

Pharmacy Times

JUNE 23, 2025

This act…allowed a pathway for manufacturers to create a ‘copy’ of a licensed patent product to make it cheaper and more discounted,” Soefje, director of pharmacy cancer care services and associate professor of pharmacy at Mayo Clinic in Rochester, Minnesota, said at the HOPA conference.

FDA 65

FDA Compounding Pharmacies Dosage Hospitals 65

Pharmacy Times

JUNE 19, 2025

1 "Immunotherapy given neoadjuvantly may not be the appropriate treatment strategy for patients with high fusion,” said Kaushal Parikh, MD, from Mayo Clinic. “In Mandatory ALK fusion testing should become part of the standard of care to better personalize treatments to a patient’s specific ALK variant.

Chemotherapy 73

Chemotherapy Compounding Pharmacies Hospitals Immunization 73